BAC Water 10mL
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.

SKU: PCUK-BPCTB10 • Batch: 100244
BPC-157 and TB-500 combined in a single 10mg vial for research examining their tissue-repair and anti-inflammatory pathways together. 99.0% combined HPLC purity, COA verified.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilised peptides.
A triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
Purity independently verified at a leading Australian university via HPLC & mass spectrometry.
Our BPC-157 + TB-500 Blend combines two of the most researched healing peptides into a single lyophilised preparation at a 1:1 ratio. BPC-157 (pentadecapeptide, 15 amino acids) and TB-500 (synthetic Thymosin Beta-4 fragment, Ac-LKKTETQ) are supplied together at 99.0% total HPLC purity with a full Certificate of Analysis covering both components.
BPC-157 acts via angiogenesis, nitric oxide modulation, and growth factor upregulation pathways. TB-500 is derived from Thymosin Beta-4, an actin-sequestering protein that promotes cell migration, proliferation, and angiogenesis. Research has explored their potential synergy in tissue repair contexts where both angiogenic and anti-inflammatory mechanisms are of interest.
Both components are independently quality-tested before blending to ensure each meets purity specifications, providing confidence in the final product quality.
Each 10mg vial contains 5mg BPC-157 (Body Protection Compound-157) and 5mg TB-500 (synthetic Thymosin Beta-4 fragment Ac-LKKTETQ) as a combined lyophilised preparation.
The combined blend is verified at 99.0% HPLC purity. Both components are independently quality-tested before blending.
Store lyophilised at −20°C. Once reconstituted with BAC water, store at 2–8°C and use within 4 weeks.
Yes. Both peptides in this blend are legal to purchase for in-vitro research purposes in Australia. Not for human consumption or therapeutic use.
Yes,a full COA covering both BPC-157 and TB-500 components is available, including HPLC data, mass spec, sterility, and endotoxin results.
BPC-157 + TB-500 Blend 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to BPC-157 + TB-500. Provided for research context — not medical advice.
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK, Bolia IK, Feingold CL, et al. · The American journal of sports medicine · 2026
PMID: 41476424
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID: 41490200
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID: 41966639
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
Tewari K, Liu TP, Im C, et al. · The American journal of sports medicine · 2026
PMID: 42578445
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.